| The prognostic significance of pretreatment serum LDH level in non-small cell lung cancer | Feyyaz ÖZDEMİR,Özlen BEKTAŞ,İrfan URUÇ,Yılmaz BÜLBÜL,Murat TOPBAŞ,Halil KAVGACI,Mustafa YILMAZ,Fazıl AYDIN | 115–119 |
| The importance of pathologic complete response in rectal cancer patients treated by preoperative chemoradiotherapy | Diclehan ÜNSAL,Evrim TUNÇ,B. Bülent MENTEŞ,Aytuğ ÜNER,Yücel PAK | 120–131 |
| The effects of postoperative radiation therapy in non-small cell lung cancer treatment on overall survival and local control: Retrospective evaluation of 43 cases | Oğuz G. YILDIZ,Serdar SOYUER,Eray KARAHACIOĞLU,Okan ORHAN,Kadir UÇAR,Mehmet BİLGİN,Bünyamin KAPLAN | 132–137 |
| Prognostic significance of NF-KB in unresectable non-small cell carcinoma of the lung treated with concomittant chemoradiotherapy | Celalettin EROĞLU,Işın SOYUER,Serdar SOYUER,Oğuz G. YILDIZ,Okan ORHAN,METE GÜNDOĞ,Metin ÖZKAN,Özlem ER,Mustafa ALTINBAŞ,Bünyamin KAPLAN | 138–143 |
| Results of treatment regime of FLAG-ida-cyclosporine in acute leukemia patients refractory to FLAG salvage regime | MEHMET SÖNMEZ,Mustafa YILMAZ,Murat ERKUT,ELİF AKDOĞAN,Ahmet DURMUŞ,Serdar B. OMAY,Ercüment OVALI | 144–148 |
| Daunorubicin induced blue-gray hyperpigmentation: A case report | Orhan AYYILDIZ,DEDE ŞİT,Murat SÖKER,A. Kemal KADİROĞLU,A. Haluk YEŞİLBAĞDAN | 149–152 |
| Priapizm ile ortaya çıkan kronik myeloid lösemi olgusu: Olgu sunumu | A. Egemen AVCI,Fatih KURTULUŞ,Adem FAZLIOĞLU,Serkan KESKİN,Özgür GÜÇTAŞ,Mete ÇEK | 153–155 |
| Individualization of antineoplastic chemotherapy and pharmacogenetic | Özlem KARAKURT,Mehmet MELLİ | 156–164 |
| The role of epidermal growth factor receptor inhibitors in the non-small cell lung cancer treatment | Özden ALTUNDAĞ,Kadri ALTUNDAĞ | 165–174 |